{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T14:54:39Z","timestamp":1791125679842,"version":"4.1.0"},"reference-count":50,"publisher":"American Society of Hematology","issue":"6","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2011,8,11]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Femoral and lumbar bone mineral densities (BMDs) were measured in 159 adults enrolled in the Leuc\u00e9mies de l'Enfant et de l'Adolescent program, a French prospective multicentric cohort of childhood leukemia survivors. BMDs were expressed as Z-scores, and multivariate linear regression analyses were used to construct association models with potential risk factors. Mean age at evaluation and follow-up was 23 and 14.7 years, respectively. In the whole cohort, mean femoral Z-score was \u22120.19 \u00b1 0.08. Two factors were associated with lower femoral BMD transplantation (\u22120.49 \u00b1 0.15 vs \u22120.04 \u00b1 0.10 in the chemotherapy group; P = .006) and female sex (\u22120.34 \u00b1 0.10 vs \u22120.03 \u00b1 0.13; P = .03). Among patients who received a transplant, the only significant risk factor was hypogonadism (\u22120.88 \u00b1 0.16 vs \u22120.10 \u00b1 0.23; P = .04). A slight reduction in lumbar BMD (mean Z-score, \u22120.37 \u00b1 0.08) was detected in the whole cohort without difference between the transplantation and chemotherapy groups. Among patients who received a transplant, younger age at transplantation was correlated with a low lumbar BMD (P = .03). We conclude that adults who had received only chemotherapy for childhood leukemia have a slight reduction in their lumbar BMD and a normal femoral BMD. Patients who received a transplant with gonadal deficiency have a reduced femoral BMD which might increase the fracture risk later in life.<\/jats:p>","DOI":"10.1182\/blood-2011-01-332866","type":"journal-article","created":{"date-parts":[[2011,5,20]],"date-time":"2011-05-20T05:19:37Z","timestamp":1305868777000},"page":"1481-1489","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":48,"title":["Bone mineral density in adult survivors of childhood acute leukemia: impact of hematopoietic stem cell transplantation and other treatment modalities"],"prefix":"10.1182","volume":"118","author":[{"given":"Marion","family":"Le Meignen","sequence":"first","affiliation":[{"name":"Department of Paediatric Onco-hematology, Hospital L'Archet II, Nice, France;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pascal","family":"Auquier","sequence":"additional","affiliation":[{"name":"Research Unit EA 3279 and Department of Public Health, H\u00f4pital Nord, Marseille, France;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincent","family":"Barlogis","sequence":"additional","affiliation":[{"name":"Department of Paediatric Hematology, Children's Hospital of La Timone, Marseille, France;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas","family":"Sirvent","sequence":"additional","affiliation":[{"name":"Department of Paediatric Onco-hematology, Hospital Arnaud de Villeneuve, Montpellier, France; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Audrey","family":"Contet","sequence":"additional","affiliation":[{"name":"Department of Paediatric Onco-Hematology, Children's Hospital of Brabois, Vandoeuvre Les Nancy, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie-Claude","family":"Simeoni","sequence":"additional","affiliation":[{"name":"Research Unit EA 3279 and Department of Public Health, H\u00f4pital Nord, Marseille, France;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claire","family":"Galambrun","sequence":"additional","affiliation":[{"name":"Department of Paediatric Hematology, Children's Hospital of La Timone, Marseille, France;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marilyne","family":"Poir\u00e9e","sequence":"additional","affiliation":[{"name":"Department of Paediatric Onco-hematology, Hospital L'Archet II, Nice, France;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pascal","family":"Chastagner","sequence":"additional","affiliation":[{"name":"Department of Paediatric Onco-Hematology, Children's Hospital of Brabois, Vandoeuvre Les Nancy, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Play","sequence":"additional","affiliation":[{"name":"Department of Paediatric Hematology, Children's Hospital of La Timone, Marseille, France;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Virginie","family":"Villes","sequence":"additional","affiliation":[{"name":"Research Unit EA 3279 and Department of Public Health, H\u00f4pital Nord, Marseille, France;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie","family":"Berbis","sequence":"additional","affiliation":[{"name":"Research Unit EA 3279 and Department of Public Health, H\u00f4pital Nord, Marseille, France;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Herv\u00e9","family":"Chambost","sequence":"additional","affiliation":[{"name":"Department of Paediatric Hematology, Children's Hospital of La Timone, Marseille, France;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre","family":"Bordigoni","sequence":"additional","affiliation":[{"name":"Department of Paediatric Onco-Hematology, Children's Hospital of Brabois, Vandoeuvre Les Nancy, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G\u00e9rard","family":"Michel","sequence":"additional","affiliation":[{"name":"Department of Paediatric Hematology, Children's Hospital of La Timone, Marseille, France;"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"issue":"11","key":"2019111808380203500_B1","doi-asserted-by":"crossref","first-page":"1774","DOI":"10.1002\/jbmr.5650111122","article-title":"Altered mineral metabolism and bone mass in children during treatment for acute lymphoblastic leukemia.","volume":"11","author":"Halton","year":"1996","journal-title":"J Bone Miner Res"},{"issue":"4","key":"2019111808380203500_B2","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1097\/00043426-199807000-00008","article-title":"Longitudinal evaluation of bone mineral density in children receiving chemotherapy.","volume":"20","author":"Henderson","year":"1998","journal-title":"J Pediatr Hematol Oncol"},{"issue":"9","key":"2019111808380203500_B3","doi-asserted-by":"crossref","first-page":"3174","DOI":"10.1210\/jcem.84.9.5968","article-title":"Alterations in bone turnover and impaired development of bone mineral density in newly diagnosed children with cancer: a 1-year prospective study.","volume":"84","author":"Arikosky","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"2019111808380203500_B4","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1067\/mpd.2002.125728","article-title":"Altered bone mineral density and body composition and increased fracture risk in childhood acute lymphoblastic leukemia.","volume":"141","author":"Van der Sluis","year":"2002","journal-title":"J Pediatr"},{"issue":"2","key":"2019111808380203500_B5","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1385\/JCD:5:2:167","article-title":"Bone mineral assessment with tibial ultrasonometry and dual-energy X-ray absorptiometry in long-term survivors of acute lymphoblastic leukemia in childhood.","volume":"5","author":"Lequin","year":"2002","journal-title":"J Clin Densitom"},{"issue":"7","key":"2019111808380203500_B6","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1200\/JCO.2004.04.199","article-title":"Skeletal morbidity in childhood acute lymphoblastic leukemia.","volume":"22","author":"Mandel","year":"2004","journal-title":"J Clin Oncol"},{"issue":"1","key":"2019111808380203500_B7","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1002\/pbc.20437","article-title":"No difference between prednisolone and dexamethasone treatment in bone mineral density and growth in long term survivors of childhood acute lymphoblastic leukemia.","volume":"46","author":"Van Beek","year":"2006","journal-title":"Pediatr Blood Cancer"},{"issue":"4","key":"2019111808380203500_B8","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1002\/1096-911X(20001001)35:4<415::AID-MPO4>3.0.CO;2-9","article-title":"Bone mineral density, body composition, and height in long-term survivors of acute lymphoblastic leukemia in childhood.","volume":"35","author":"van der Sluis","year":"2000","journal-title":"Med Pediatr Oncol"},{"issue":"6","key":"2019111808380203500_B9","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1067\/mpd.2001.113102","article-title":"Normal bone mineral density after treatment for childhood acute lymphoblastic leukemia diagnosed between 1991 and 1998.","volume":"138","author":"Kadan-Lottick","year":"2001","journal-title":"J Pediatr"},{"issue":"4","key":"2019111808380203500_B10","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1097\/00043426-199611000-00006","article-title":"Bone density in survivors of childhood malignancies.","volume":"18","author":"Henderson","year":"1996","journal-title":"J Pediatr Hematol Oncol"},{"issue":"12","key":"2019111808380203500_B11","doi-asserted-by":"crossref","first-page":"3752","DOI":"10.1200\/JCO.1998.16.12.3752","article-title":"Bone mass after treatment for acute lymphoblastic leukemia in childhood.","volume":"16","author":"Nysom","year":"1998","journal-title":"J Clin Oncol"},{"key":"2019111808380203500_B12","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1002\/(SICI)1097-0215(1998)78:11+<44::AID-IJC13>3.0.CO;2-A","article-title":"Bone mineral density in long-term survivors of childhood cancer.","volume":"11","author":"Hesseling","year":"1998","journal-title":"Int J Cancer Suppl"},{"issue":"3","key":"2019111808380203500_B13","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1097\/00043426-199805000-00009","article-title":"Reduced bone mineral density in long-term survivors of childhood acute lymphoblastic leukemia.","volume":"20","author":"Arikosky","year":"1998","journal-title":"J Pediatr Hematol Oncol"},{"issue":"2","key":"2019111808380203500_B14","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1046\/j.1365-2265.1999.00654.x","article-title":"Bone mineral density and markers of bone turnover in young adult survivors of childhood lymphoblastic leukaemia.","volume":"50","author":"Hoorweg-Nijman","year":"1999","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"11\u201312","key":"2019111808380203500_B15","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1038\/sj.bjc.6690296","article-title":"Reduced bone mineral density in young adults following cure of acute lymphoblastic leukemia in childhood.","volume":"79","author":"Brennan","year":"1999","journal-title":"Br J Cancer"},{"issue":"4 Pt 1","key":"2019111808380203500_B16","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1203\/00006450-199904010-00014","article-title":"Relative osteopenia after treatment for acute lymphoblastic leukemia.","volume":"45","author":"Warner","year":"1999","journal-title":"Pediatr Res"},{"issue":"5","key":"2019111808380203500_B17","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1038\/sj.leu.2402078","article-title":"Bone mineral decrements in survivors of childhood acute lymphoblastic leukemia: frequency of occurrence and risk factors for their development.","volume":"15","author":"Kaste","year":"2001","journal-title":"Leukemia"},{"issue":"6","key":"2019111808380203500_B18","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1359\/jbmr.2002.17.6.1073","article-title":"Male sex and low physical activity are associated with reduced spine bone mineral density in survivors of childhood acute lymphoblastic leukemia.","volume":"17","author":"Tillmann","year":"2002","journal-title":"J Bone Miner Res"},{"issue":"3","key":"2019111808380203500_B19","doi-asserted-by":"crossref","first-page":"e705","DOI":"10.1542\/peds.2007-1396","article-title":"Bone mineral density deficits in survivors of childhood cancer: long-term follow-up guidelines and review of the literature.","volume":"121","author":"Wasilewski-Masker","year":"2008","journal-title":"Pediatrics"},{"issue":"9","key":"2019111808380203500_B20","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1038\/sj.bmt.1705821","article-title":"Health status and quality of life in long-term survivors of childhood leukaemia: the impact of haematopoietic stem cell transplantation.","volume":"40","author":"Michel","year":"2007","journal-title":"Bone Marrow Transplant"},{"issue":"6","key":"2019111808380203500_B21","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1016\/j.bone.2008.08.106","article-title":"International Society for Clinical Densitometry 2007 official adult and pediatric positions.","volume":"43","author":"Lewiecki","year":"2008","journal-title":"Bone"},{"key":"2019111808380203500_B22","first-page":"148","article-title":"Treatment of acute lymphoblastic leukemia French protocol Fralle 83-87.","volume":"6","author":"Schaison","year":"1992","journal-title":"Leukemia"},{"issue":"12","key":"2019111808380203500_B23","doi-asserted-by":"crossref","first-page":"2082","DOI":"10.1038\/sj.leu.2403867","article-title":"Treatment of childhood acute myeloblastic leukemia: dose intensification improves outcome and maintenance therapy is of no benefit\u2013multicenter studies of the French LAME (Leucemie Aigue Myeloblastique Enfant) Cooperative Group.","volume":"19","author":"Perel","year":"2005","journal-title":"Leukemia"},{"issue":"9","key":"2019111808380203500_B24","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1200\/JCO.2007.12.2820","article-title":"Prognostic factors for leukemic induction failure in children with acute lymphoblastic leukemia and outcome after salvage therapy: the FRALLE 93 study.","volume":"26","author":"Oudot","year":"2008","journal-title":"J Clin Oncol"},{"issue":"6","key":"2019111808380203500_B25","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1016\/j.ejca.2008.02.011","article-title":"Treatment of childhood T-cell lymphoblastic lymphoma according to the strategy for acute lymphoblastic leukaemia, without radiotherapy: long term results of the EORTC CLG 58881 trial.","volume":"44","author":"Uyttebroeck","year":"2008","journal-title":"Eur J Cancer"},{"key":"2019111808380203500_B26","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1007\/BF01621864","article-title":"Determinants of peak bone mass.","volume":"3","author":"Johnston","year":"1993","journal-title":"Osteoporis Int"},{"issue":"1","key":"2019111808380203500_B27","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1007\/BF01623938","article-title":"Bone mineral acquisition during adolescence and early adulthood: a study in 574 healthy females 10-24 years of age.","volume":"6","author":"Sabatier","year":"1996","journal-title":"Osteoporos Int"},{"issue":"1","key":"2019111808380203500_B28","first-page":"1","article-title":"Osteoporosis prevention, diagnosis, and therapy.","volume":"17","year":"2000","journal-title":"NIH Consens Statement Online"},{"issue":"2 Pt 1","key":"2019111808380203500_B29","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/S0022-3476(05)80536-0","article-title":"Osteoporosis after cranial irradiation for acute lymphoblastic leukemia.","volume":"117","author":"Gilsanz","year":"1990","journal-title":"J Pediatr"},{"issue":"1","key":"2019111808380203500_B30","first-page":"118","article-title":"Bone mineral status in Growth-hormone deficient males with isolated and multiple pituitary deficiencies of childhood onset.","volume":"74","author":"Kaufman","year":"1992","journal-title":"J Clin Endocrinol Metab"},{"issue":"12","key":"2019111808380203500_B31","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1136\/adc.67.12.1472","article-title":"Growth hormone deficiency during puberty reduces adult bone mineral density.","volume":"67","author":"Hyer","year":"1992","journal-title":"Arch Dis Child"},{"issue":"1\u20132","key":"2019111808380203500_B32","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1159\/000184765","article-title":"Role of growth hormone and sex steroids in achieving and maintaining normal bone mass.","volume":"45","author":"Holmes","year":"1996","journal-title":"Horm Res"},{"key":"2019111808380203500_B33","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1111\/j.1651-2227.1994.tb13276.x","article-title":"Bone mineralization after treatment of growth hormone deficiency in survivors of childhood malignancy.","volume":"399","author":"Nussey","year":"1994","journal-title":"Acta Pediatr Suppl"},{"issue":"10","key":"2019111808380203500_B34","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1007\/s00198-007-0394-0","article-title":"Glucocorticoid-induced osteoporosis: pathophysiology and therapy,","volume":"18","author":"Canalis","year":"2007","journal-title":"Osteop Int"},{"issue":"10","key":"2019111808380203500_B35","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1016\/j.amjmed.2010.02.028","article-title":"Drug-induced osteoporosis: mechanisms and clinical implications.","volume":"123","author":"Mazziotti","year":"2010","journal-title":"Am J Med"},{"issue":"3","key":"2019111808380203500_B36","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1002\/1097-0142(197003)25:3<580::AID-CNCR2820250313>3.0.CO;2-M","article-title":"Osteoporotic fractures secondary to methotrexate therapy of acute leukemia in remission.","volume":"25","author":"Ragab","year":"1970","journal-title":"Cancer"},{"issue":"125","key":"2019111808380203500_B37","first-page":"139","article-title":"Fractures in children treated with methotrexate for leukemia.","author":"Stanisavljevic","year":"1977","journal-title":"Clin Orthop Relat Res"},{"issue":"12","key":"2019111808380203500_B38","doi-asserted-by":"crossref","first-page":"4536","DOI":"10.1210\/jc.2006-2870","article-title":"Bone loss and its management in long-term survivors from allogeneic stem cell transplantation.","volume":"92","author":"Tauchmanov\u00e0","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"2019111808380203500_B39","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1038\/sj.bmt.1701275","article-title":"Bone mineral density in patients undergoing bone marrow transplantation for myeloid malignancies.","volume":"22","author":"Bhatia","year":"1998","journal-title":"Bone Marrow Transplant"},{"issue":"2","key":"2019111808380203500_B40","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1038\/sj.bmt.1702131","article-title":"Bone mass after allogenic BMT for childhood leukemia or lymphoma.","volume":"25","author":"Nysom","year":"2000","journal-title":"Bone Marrow Transplant"},{"issue":"4","key":"2019111808380203500_B41","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1097\/01.TP.0000076627.70050.53","article-title":"Bone mineral density in pediatric transplant recipients.","volume":"76","author":"Daniels","year":"2003","journal-title":"Transplantation"},{"issue":"4","key":"2019111808380203500_B42","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1038\/sj.bmt.1704360","article-title":"Bone mineral density and osteonecrosis in survivors of childhood allogenic bone marrow transplantation.","volume":"33","author":"Kaste","year":"2004","journal-title":"Bone Marrow Transplant"},{"issue":"1","key":"2019111808380203500_B43","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/bmt.2010.198","article-title":"Screening, prevention and management of osteoporosis and bone loss in adult and pediatric hematopoietic cell transplant recipients.","volume":"46","author":"McClune","year":"2011","journal-title":"Bone Marrow Transplant"},{"issue":"11","key":"2019111808380203500_B44","doi-asserted-by":"crossref","first-page":"5058","DOI":"10.1210\/jc.2002-020800","article-title":"Long-lasting bone damage detected by dual energy X-ray absorbtiometry, phalangeal osteosonogrammetry and in vitro growth of marrow stroma cells after allogenic stem cell transplantation.","volume":"87","author":"Tauchmanova","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"2019111808380203500_B45","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1038\/sj.bmt.1703317","article-title":"Recovery of bone mass and normalization of bone turnover in long-term survivors of allogenic bone marrow transplantation.","volume":"29","author":"Kananen","year":"2002","journal-title":"Bone Marrow Transplant"},{"issue":"10","key":"2019111808380203500_B46","doi-asserted-by":"crossref","first-page":"3635","DOI":"10.1182\/blood-2003-09-3081","article-title":"Bone loss following hematopoietic stem cell transplantation, a long term follow-up.","volume":"103","author":"Schulte","year":"2004","journal-title":"Blood"},{"issue":"3","key":"2019111808380203500_B47","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1359\/jbmr.1999.14.3.342","article-title":"Mechanisms of bone loss following allogeneic and autologous hemopoietic stem cell transplantation.","volume":"14","author":"Ebeling","year":"1999","journal-title":"J Bone Miner Res"},{"issue":"4","key":"2019111808380203500_B48","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1038\/sj.bmt.1701586","article-title":"A prospective study of bone loss and turnover after allogenic bone marrow transplantation: effect of calcium supplementation with or without calcitonin.","volume":"23","author":"Valimaki","year":"1999","journal-title":"Bone Marrow Transplant"},{"issue":"5","key":"2019111808380203500_B49","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1053\/bbmt.2001.v7.pm11400947","article-title":"Bone density loss after allogeneic stem cell transplantation: a prospective study.","volume":"7","author":"Stern","year":"2001","journal-title":"Biol Blood Marrow Transplant"},{"issue":"8837","key":"2019111808380203500_B50","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/0140-6736(93)92555-8","article-title":"Bone density at various sites for prediction of hip fractures. The study of Osteoporotic Fractures Research Group.","volume":"341","author":"Cummings","year":"1993","journal-title":"Lancet"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/118\/6\/1481\/1346186\/zh803211001481.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/118\/6\/1481\/1346186\/zh803211001481.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,11,18]],"date-time":"2019-11-18T14:04:34Z","timestamp":1574085874000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/118\/6\/1481\/29117\/Bone-mineral-density-in-adult-survivors-of"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,8,11]]},"references-count":50,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2011,8,11]]}},"URL":"https:\/\/doi.org\/10.1182\/blood-2011-01-332866","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,8,11]]}}}